In:
APMIS, Wiley, Vol. 122, No. 6 ( 2014-06), p. 552-555
Abstract:
U reaplasma urealyticum is an opportunistic pathogen during pregnancy and in newborns. Other clinical problems related to U . urealyticum infections are: no susceptibility to cell wall‐active drugs, limits of antibiotic treatment in pregnancy, and spread of antimicrobial resistance. In addition, the results of antimicrobial susceptibility against U . urealyticum from various countries are few and controversial. The antimicrobial susceptibility of U . urealyticum , isolated from cervical swabs and collected from outpatient childbearing‐aged women in I taly from 2009 to 2012, was performed against fluoroquinolones, macrolides, streptogramin and tetracyclines, using an available biochemical commercial kit and a specific solid culture medium, to improve the therapeutic management of these pathogenic agents. U reaplasma urealyticum was detected in 49.4% of samples, but significant bacterial load was revealed in 29.8%. In vitro tetracyclines showed the best activity against U . urealyticum , followed by streptogramin, macrolides, and fluoroquinolones.
Type of Medium:
Online Resource
ISSN:
0903-4641
,
1600-0463
DOI:
10.1111/apm.2014.122.issue-6
Language:
English
Publisher:
Wiley
Publication Date:
2014
detail.hit.zdb_id:
2098213-6
SSG:
12
Bookmarklink